X. Clinical Presentations 1
20th Annual NPWH Premier Women's Healthcare Conference
1.25 CE, 0.5 Rx (NCC Code 2B)
Non-Invasive Prenatal Testing: Is This the Future of Prenatal Diagnosis?
Patricia Geraghty, MSN, FNP-BC, WHNP
Cell free DNA prenatal screening is a relatively new but increasingly important part of prenatal care. This presentation provides a foundation of understanding the physiology and technology of sampling and analyzing cell free DNA. Accuracy of screening is compared among the various sampling of technologies (massively parallel shotgun sequencing, targeted sequencing, and single nucleotide polymorphisms) and to existing screening tests. Threats to accuracy/validity are discussed. Different professional group guidelines are reviewed. Pre-testing and post-testing patient counseling is outlined. Resources for continued knowledge development are provided.
Pre-Term Labor: Utilization of Antenatal Steroids, Tocolytics, and Magnesium Sulfate
Tiameko R. Overton, BSN, MSN
This session will help the clinician to identify and appropriately manage patients at risk for or in active preterm labor.